Treatment With TNF Blockade, Infliximab, in Patients With Myositis

PHASE2/PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Refractory Myositis
Interventions
DRUG

Infliximab

All Listed Sponsors
collaborator

Schering-Plough

INDUSTRY

collaborator

Medical Research Council

OTHER_GOV

lead

Karolinska Institutet

OTHER

NCT00443222 - Treatment With TNF Blockade, Infliximab, in Patients With Myositis | Biotech Hunter | Biotech Hunter